14 August 2019 | News
Glen Research provides a comprehensive range of reagents for synthesis, modification, labeling and purification of DNA and RNA oligonucleotides.
image credit- discovermagazine.com
Sterling, VA and Hyderabad, India – Glen Research, a Maravai LifeSciences company and leader in the development of a wide range of reagents for DNA and RNA synthesis, announced today a distribution agreement with BioServe Biotechnologies India Pvt Limited, a Hyderabad-based subsidiary of REPROCELL Inc. Under the terms of the agreement, BioServe will distribute Glen Research products and services in India, Sri Lanka, Bangladesh and Nepal.
Glen Research provides a comprehensive range of reagents for synthesis, modification, labeling and purification of DNA and RNA oligonucleotides. Through this distribution agreement BioServe will market Glen Research reagents and products to Indian researchers, CMOs and biopharmaceutical companies involved in oligonucleotide synthesis.
Lalith Kishore, CEO of REPROCELL South Asia commented, “This agreement will bring world-class nucleic acid synthesis reagents to India and will accelerate DNA- and RNA-based therapeutics and diagnostics projects. We look forward to making this partnership work for our customers in academia and industry.”
"This agreement with BioServe increases the availability of our high-quality oligonucleotide reagents across the Indian subcontinent," commented Ravi Vinayak, Ph.D., general manager of global channel distribution for Maravai LifeSciences. “In partnership with BioServe we now have access to a much larger customer base.”